Table 1 Demography and clinico-pathological data of patients with head and neck squamous cell carcinoma (HNSCC)
Men | Women | All | |
|---|---|---|---|
(N = 230) | (N = 46) | (N = 276) | |
Demography | |||
Age (years) | |||
Mean (SD) | 58.2 (8.5) | 57.0 (11.4) | 58.0 (9.0) |
Median (IQR) | 58.0 (12.0) | 58.0 (15.0) | 58.0 (12.0) |
Range | 41–77 | 32–77 | 32–77 |
Education (years) | |||
< 10 | 164 (73.3 %) | 25 (54.4 %) | 189 (68.5 %) |
≥ 10 | 66 (28.7 %) | 21 (45.6 %) | 87 (31.5 %) |
Clinico-pathological characteristics | |||
Stage (UICCa) | |||
I | 19 (8.3 %) | 3 (6.5 %) | 22 (8.0 %) |
II | 28 (12.2 %) | 5 (10.9 %) | 33 (12.0 %) |
III | 19 (8.3 %) | 8 (17.4 %) | 27 (9.8 %) |
IV | 106 (46.1 %) | 19 (41.3 %) | 125 (45.3 %) |
Missing | 58 (25.2 %) | 11 (23.9 %) | 69 (25.0 %) |
Tumor site | |||
C01-C06 (Oral cavity) | 70 (30.4 %) | 19 (41.3 %) | 89 (32.3 %) |
C09 (Tonsils) | 34 (14.8 %) | 5 (10.9 %) | 39 (14.1 %) |
C10-C13 (Pharynx) | 56 (24.4 %) | 16 (34.8 %) | 72 (26.1 %) |
C32 (Larynx) | 70 (30.4 %) | 6 (13.0 %) | 76 (27.5 %) |
Radiotherapy | |||
No/unknown | 78 (33.9 %) | 14 (30.4 %) | 92 (33.3 %) |
Yes | 152 (66.1 %) | 32 (69.6 %) | 184 (66.7 %) |
Surgery | |||
No/unknown | 38 (16.5 %) | 10 (21.7 %) | 48 (17.4 %) |
Yes | 192 (83.5 %) | 36 (78.3 %) | 228 (82.6 %) |
Chemotherapy | |||
No/unknown | 145 (63.0 %) | 24 (52.2 %) | 169 (61.2 %) |
Yes | 85 (37.0 %) | 22 (47.8 %) | 107 (38.8 %) |
HPV status (16, 18) | |||
Negative | 142 (61.7 %) | 25 (54.4 %) | 167 (60.5 %) |
Positive | 19 (8.3 %) | 5 (10.9 %) | 24 (8.7 %) |
Missing | 69 (30.0 %) | 16 (34.8 %) | 85 (30.8 %) |